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Background: Although previous studies suggest a high frequency of psychotic symptoms in DSM-IV Borderline
Personality Disorder (BPD) there is currently no consensus on their prevalence and characteristics (type, frequency,
duration, location etc.). Similarly, there are few papers addressing psychotic reactivity, the crucial aspect of BPD
included in the ninth criterion for DSM-IV BPD, which remained unchanged in DSM-IV-TR and DSM-5. The purposes
of the present study were to compare thought and perception disorders in patients with DSM-IV BPD and
schizophrenia (SC), investigating their relationship with social functioning.
Methods: Thought and perception disorders and social functioning over the previous two years were assessed by
the Diagnostic Interview for Borderline Revised (DIB-R) and Personal and Social Performance scale (PSP) respectively
in outpatients with DSM-IV BPD (n = 28) or DSM-IV SC (n = 28).
Results: Quasi-psychotic thought (i.e. transient, circumscribed and atypical psychotic experiences) was more
frequent in BPD (BPD = 82.1%, SC = 50%, p = 0.024); whereas true psychotic thought (i.e. Schneiderian first-rank,
prolonged, widespread and bizarre psychotic symptoms) was more frequent in SC (SC = 100%, BPD = 46.4%,
p < 0.001). However both types of psychotic features were prevalent in both groups. Non-delusional paranoia
(e.g. undue suspiciousness and ideas of references) was ubiquitous but was more severe in BPD than SC patients
(U(54) = 203.5, p = 0.001). In the BPD group there was a strong negative correlation between personal and social
functioning and non-delusional paranoia (τ(28) = 0.544, p = 0.002) and level of personal and social functioning was a
significant predictor of the severity of non-delusional paranoia only in the BPD group (β = −0.16, t(23) = 2.90, p = 0.008).
Conclusions: BPD patients reported less severe psychotic experiences with more frequent quasi-psychotic thought,
less frequent true psychotic thought and more severe non-delusional paranoia than SC patients. Interpersonal functioning
seems to predict non-delusional paranoia in BPD, which would validate the “stress-related paranoid ideation”, included
in the ninth diagnostic criterion for DSM-IV and DSM-5 BPD. PBD patients had higher scores on the psychotic experiences
subscale that support the use of a dimensional assessment of the severity of thought and perception disorders, for
example the Clinician-Rated Dimensions of Psychosis Symptom Severity introduced in DSM-5, Section III.
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According to the first Stern’s definition [1], Borderline
Personality Disorder (BPD) is a nosographic entity on the
border between neurosis and psychosis. This definition
received support from several authors who worked on
pseudo-neurotic disorders which were too severe to benefit
from classical psychoanalytic treatment, or psychotic-like
disorders which were insufficiently severe to be considered
psychotic disorders [2-5]. According to psychodynamic
perspectives, patients with BPD are usually capable of
reality testing, but may lose this capacity and suffer tran-
sient psychotic episodes under severe stress (especially
when they are exposed to real or imagined abandonment
[6]), during psychotherapy (so called ‘transference psych-
osis’) [5,7,8], or under the influence of alcohol or other
drugs [7,9-12].
This was consistent with both DSM-III (Diagnostic
and Statistical Manual of Mental Disorders, 3rd ed.) [13]
and DSM-III-R [14], which reported that in BPD transi-
ent psychotic symptoms may occur during periods of ex-
treme stress; however, none of the eight criteria for
DSM-III/ DSM-III-R BPD referred to psychotic features
and instead the classification of concurrent psychotic
symptoms was covered by Axis I psychotic disorders. In
contrast with DSM-III and DSM-III-R, some authors re-
ported high rates of some peculiar psychotic-like features
when assessing DSM-III and DSM-III-R BPD [15-20].
Zanarini and colleagues [21] conducted an in-depth evalu-
ation of the cognitive features of BPD comparing three
clinical groups (BPD, n = 50; other personality disorders,
n = 55; schizophrenia, n = 32) with healthy controls
(n = 46). They used the Diagnostic Interview for Border-
line Revised (DIB-R) [22] to assess psychopathology
over the previous two years and the Structured Clinical
Interview for DSM-III (SCID) [23] to evaluate lifetime
psychotic episodes. Using the DIB-R, quasi-psychotic
thought characterized by transient (lasting less than two
days), circumscribed (affecting not more than two areas
of life ) or atypical psychotic symptoms (based on reality
or totally fantastic), were observed in 20 patients (40%)
with BPD, one patient (1.8%) with other personality dis-
order (PD), and none of the patients with schizophrenia
(SC), whereas only patients with SC reported true psych-
otic thought, defined as prolonged, widespread, bizarre and
stereotypical psychotic symptoms, i.e. Schneiderian
first-rank symptoms. Using SCID all 32 patients with
SC, seven patients (14%) with BPD and two patients
(2.6%) with other PD reported one or more lifetime
psychotic episodes. In BPD patients these occurred only
in the context of either co-morbid substance use dis-
order or co-morbid affective disorder as previously re-
ported by Pope and colleagues [17]. These findings [21]
confirmed the predicted specificity of true psychotic
thought for SC and extended previous reports of theprevalence of transient psychotic-like symptoms in
BPD, suggesting that quasi-psychotic thought was a
highly discriminant sign and therefore “virtually pathog-
nonomic” for BPD.
In DSM-IV [24] the section on BPD was supple-
mented: a ninth criterion for a categorical diagnosis of
BPD, the presence of “transient stress-related paranoid
ideation or severe dissociative symptoms” was added; it
was stated that the severity and duration of psychotic
symptoms should not be such as to warrant an additional
diagnosis of psychotic disorder, and the development of
psychotic-like symptoms (e.g. hallucinations, body-image
distortion, ideas of references, and hypnagogic phenom-
ena) during times of stress was recognized as an associ-
ated feature supporting diagnosis of BPD. However no
explicit reference to “regression proneness” or the loss of
reality testing was included in DSM-IV and this drew a
certain amount of criticism [11].
Since the introduction of DSM-IV, some studies have re-
ported high rates of psychotic symptoms in BPD [25-30],
but few of these studies used a structured interview cap-
able of discriminating between quasi-psychotic thoughts
and true psychotic thoughts in the manner of DIB-R. For
instance, Yee and colleagues [29] found that 29.2% of 171
patients being treated for DSM-IV BPD reported ‘hearing
voices’ on Symptom-Checklist-90 (SCL-90) [31], but an
in-depth evaluation (covering the frequency, duration and
type of perception disorder) was only conducted in a non-
random subsample of ten cases. On this basis the authors
suggested that hallucinatory phenomena were an ongoing,
pervasive feature of BPD and were not atypical for this pa-
tient group.
Two other studies [27,28] compared patients with BPD
and SC using SCID-II to diagnose DSM-IV BPD and the
Psychotic Symptom Rating Scale (PSYRATS) [32] to as-
sess the subjective characteristics of hallucinations and de-
lusions (e.g. frequency, duration, amount of distress etc.).
Kingdon and colleagues [27] found that 29% of 33 patients
with BPD experienced paranoid delusions compared with
61% of 59 patients with SC and 65% of 19 patients with a
diagnosis of both BPD and SC. Only 50% of patients with
BPD experienced auditory hallucinations compared with
66% of SC patients and 90% of patients with SC and BPD;
there were no significant differences in the frequency, dur-
ation or location of hallucinations; however substance use
was not taken into account in this study. Slotema and col-
leagues [28] explicitly excluded patients with alcohol
abuse, substance use or current delusions; they recruited a
sample of 38 women with BPD, 51 women with SC and
66 healthy women and confirmed that the frequency, dur-
ation, and location of auditory verbal hallucinations were
similar in patients with BPD and SC.
More recently, Pearse and colleagues [30] found highest
lifetime prevalence of psychotic symptoms in DSM-IV
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[33], though patients with affective and substance use
disorders were not excluded and psychotic symptoms
met DSM-IV SC criteria in 10% of the sample.
In summary, although previous studies suggest so
much high frequency of psychotic symptoms in DSM-IV
BPD than it has been recently proposed to avoid terms
like pseudo-psychotic or quasi-psychotic [34], there is
currently no consensus on their prevalence and charac-
teristics (type, frequency, duration, location etc.). Since
the introduction of the ninth criterion by the DSM-IV
task force - which remained unchanged in DSM-IV-TR
[35] and DSM-5 [36] - no study has explicitly estimated
the prevalence of quasi-psychotic thought in BPD.
Similarly, there are few papers addressing psychotic
reactivity, the crucial aspect of BPD included in the
ninth criterion for DSM-IV BPD. Suzuki and colleagues
[37] conducted an in-depth evaluation of five patients
with BPD and psychotic symptoms that provided sup-
port for the psychodynamic perspective [3,5,7], which
assigns interpersonal functioning the crucial role in the
development of both delusion and hallucinations. These
authors also distinguished between different types of
symptoms: they suggested that paranoid delusions were
due to the projection of rage and hostile feelings onto
other people, whereas hallucinations tended to occur as
a result of avoidance of an interpersonal relationship,
and the presence of both delusions and hallucinations
was a consequence of interpersonal problems in pa-
tients with a passive attitude.
More recently, Glaser and colleagues [38] explicitly in-
vestigated stress-related psychotic responses in a sample
of 65 patients with BPD and, although they did not ex-
plicitly refer to the psychodynamic framework, they re-
ported that enhanced psychotic reactivity to the stresses
of daily life was more common in BPD than in psychotic
disorders or Cluster C personality disorders. They also
found a wide range of stress-related symptoms, which
they termed reality disturbances, that seem to fit better
with the broader definition included in the DSM-IV-TR
description of BPD (psychotic-like symptoms such as
hallucinations, body-image distortion, ideas of refer-
ences, hypnagogic phenomena) than with the narrowly
defined ninth diagnostic criterion for DSM-IV-TR BPD
(i.e. paranoid and dissociative ideation).
In order to assess whether the transition from DSM-III
to DSM-IV led to changes in reports of thought and per-
ception disorders in BPD and whether this psychopath-
ology is a reaction to interpersonal functioning, the aims
of the present study were (1) to describe perception and
thought disorders in a group of outpatients with DSM-IV
BPD, comparing their symptoms with those of outpatients
with DSM-IV SC; and (2) to explore relationship between
these symptoms and function searching for possiblecorrelations between perception and thought disorders
and personal and social functioning in both groups and
subsequently estimating the extent to which level of
personal and social functioning predicts perception
and thought disorders in both groups.
Methods
Sample and procedures
The research protocol of the present cross-sectional
comparative study was approved by the Research Ethics
Committee of the Azienda Sanitaria Locale [local health
authority] TO2 (Turin, Italy) and therefore the study was
conducted in accordance with the Helsinki Declaration.
All outpatients who accessed the Centro di Salute
Mentale – Distretto I (CSM; District 1 Centre for Mental
Health) of the Giulio Maccacaro Mental Health Depart-
ment, Turin from January 2011 to March 2011 were in-
vited to participate in the study, but only those who met
the eligibility criteria and gave written informed consent
were enrolled. Eligibility criteria were as follows: (1) under
he care of CSM for at least two years for a BPD or SC,
(2) aged 18–45 years, and (3) completed primary education.
All enrolled patients were screened using the Struc-
tured Clinical Interview for DSM-IV Axis I (SCID-I) [39]
and the Structured Clinical Interview for DSM-IV Axis
II (SCID-II) [40] and assigned to the BPD group or SC
group; patients with both SC and BPD were excluded
from the study as were patients with current DSM-IV
substance use disorder or current DSM-IV mood disorder.
Although all patients accessing the CSM were treated
in accordance with evidence-based recommendations
provided by American Psychiatric Association Practice
Guidelines [41], information about pharmacological treat-
ment were limited to current antipsychotic treatment only,
and they were collected from clinical records as dichotom-
ous variable (yes/no).
Assessment tools
SCID-I and SCID-II are semi-structured interview pro-
tocols with a modular structure based on DSM-IV Axis I
and DSM-IV Axis II respectively. In this study they were
used to diagnose BPD, SC and substance use disorders
according to DSM-IV.
Psychotic symptoms were assessed using the cognitive
section of the DIB-R [22]. This is a one hundred and
nineteen-item, semi-structured interview that evaluates
four main areas of BPD phenomenology (affective, cog-
nitive, impulsive and interpersonal), over the previous
two years, it is currently considered the international
scientific standard for the assessment of BPD [42].
The cognitive section consists of 27 items (each item
assess a single type of cognition) grouped into three
subsections: odd thinking/ unusual perceptual experi-
ences (9 items), non-delusional paranoia (3 items) and
Table 1 Socio-demographic characteristics of the BPD
group and SC group


















Age, years 40.1(5.8) 35.2(8.08) 0.012c
SC: schizophrenia; BPD: Borderline Personality Disorder.
aPearson’s χ2 test.
bFisher’s exact test.
cPearson’s independent samples t-test.
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tions assess disturbed but non-psychotic thought and
the psychotic experiences subsection assesses quasi-
psychotic thought and true psychotic thought.
In the present study, the assessment of psychotic fea-
tures considered the total score for the DIB-R cognitive
section, the prevalence of each type of thought and scores
on the DIB-R cognitive subsections.
Personal and social functioning were assessed with the
Personal and Social Performance scale (PSP) [43]. This
is a brief structured clinical interview protocol that eval-
uates four main areas: socially useful activities (area A),
personal and social relationships (area B), self-care (area
C), and disturbing and aggressive behaviors (area D). The
PSP provides a score between 1 and 100 using a 6-point
severity scale for each area; higher scores represent better
personal and social functioning. The validity and reliability
of the PSP have already been evaluated [44,45]. Although
the standard PSP investigates functioning over the past
month, the PSP manual [43] states that longer time inter-
vals can be specified; we used a time interval of two years.
Statistical analysis
All analyses were conducted using IBM SPSS Statistics
for MACOS (Version 19, Armonk: IBM Corporation).
Pearson’s χ2 test was used for group comparison of
categorical variables. Fisher’s exact test replaced the χ2
test when any expected frequency was less than or equal
to five. The normality of the distribution of continuous
variables (i.e. age, DIBR scores, and PSP scores) was evalu-
ated by Shapiro-Wilk’s test. Normally distributed variables
were compared using an independent samples t-test and
non-normally distributed variables were evaluated using
the non-parametric Mann–Whitney U test.
The association between thought and perception dis-
orders and functioning was examined by constructing
separate correlation matrices for the BPD group and SC
group, using the DIB-R cognitive section scores, the
DIB-R cognitive subsections scores (odd thinking/un-
usual perceptual experiences, non-delusional paranoia,
psychotic experiences), the PSP total scores, and the
four PSP area scores (socially useful activities, personal
and social relationships, self-care, disturbing and aggres-
sive behaviors). The strength of bivariate correlations was
reported as Pearson’s r coefficient or as Kendall’s tau (τ)
coefficient, depending on whether distribution of the vari-
ables was normal or non-normal.
Linear regression analysis consisted of three distinct
models for each group (BPD and SC); each model used a
different DIB-R subsection score as the dependent vari-
able. All models were adjusted for significant group differ-
ences on the socio-demographic variables and included
the four PSP domains as independent variables. A p-value
of 0.05 was used to designate statistical significance.Results
A total of 64 patients gave their informed consent and
fulfilled the eligibility criteria; eight (12.5%) patients were
excluded because they had a current DSM-IV substance
use disorder (n = 4, 6.2%) or a current DSM-IV mood
disorder (n = 2, 3.1%) or a diagnosis of both BPD and SC
(n = 2, 3.1%).
Following screening with SCID-I and SCID-II 28
(50%) patients were assigned to the BPD group and 28
patients (50%) were assigned to the SC group. All pa-
tients in the SC group were taking antipsychotic drugs
in accordance with evidence-based recommendations
provided by American Psychiatric Association Practice
Guidelines [41], but none of the BPD patients were tak-
ing antipsychotic drugs.
There were no significant group differences in gender,
marital status, education or employment (Table 1). How-
ever, the mean age of the SC group was significantly
higher than that of the BPD group.
Thought and perception disorders
The DIB-R results are presented in Table 2. The mean
score for the cognitive section and the psychotic experi-
ences subsection were significantly lower for the BPD
group than the SC group (DIB-R cognitive section: t (54) =
2.79, p = 0.007; psychotic experiences subsection: U (54) =
Table 2 DIB-R cognitive section and DIB-R cognitive
subsections scores for the BPD group and SC group
SC (n = 28) BPD (n = 28)
DIB-R scores Mean(SD) Mean(SD) p




Non-delusional paranoia 4.00(1.36) 5.11(0.92) 0.001b
Psychotic experiences 12.04(4.73) 4.68(3.41) <0.001b
SC: schizophrenia; BPD: Borderline Personality Disorder.
aPearson’s independent samples t-test.
bMann–Whitney U test.
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higher mean score on the non-delusional paranoia sub-
section (U (54) = 203.50, p = 0.001). All the patients in
the BPD group reported at least one symptom of non-
delusional paranoia compared to 25 patients (89.3%) in
the SC group (Fisher’s exact test, p = 0.236). There were
no significant group differences in the mean scores on
the odd thinking/unusual perceptual experiences subsec-
tion (t (54) = −0.20, p = 0.842) and in both groups the same
proportion of patients (n = 24, 85.7%) reported at least one
type of odd thinking/unusual perceptual experience.
Results for the prevalence of different types of disor-
dered thought are presented in Table 3. All the SC patients
but only slightly less than half of the BPD patients had ex-
perienced true psychotic thought during the previous two
years (Fisher’s exact test, p < 0.001). Conversely quasi-
psychotic thought was significantly more frequent in pa-
tients with BPD than with SC (χ2 (1) = 5.10, p = 0.024). All
the patients had experienced disturbed but non-psychotic
thought, but only four (14.3%) with BPD and none with
SC had experienced only this type of disordered thought
during the previous two years.
Personal and social functioning
The personal and social functioning (Table 4) of patients
with BPD did not differ from that of SC patients in terms
of PSP total score (U (54) = 307.00, p = 0.168), socially use-
ful activities score (PSP area A, U (54) = 375.00, p = 0.860),Table 3 Prevalence of DIB-R types of thought in the BPD
group and SC group
SC (n = 28) BPD (n = 28)
DIB-R types of thought n(%) n(%) p
True psychotic thought 28(100) 13(46.4) <0.001a




SC = Schizophrenia; BPD = Borderline Personality Disorder.
aFisher’s exact test.
bPearson’s χ2 test.personal and social relationships score (PSP area B, U
(54) = 392.00, p = 1) or self-care score (PSP area C, U
(54) = 387.50, p = 0.850). Only the disturbing and ag-
gressive behaviors score (PSP area D) was significantly
worse in the BPD group (U (54) = 178.50, p < 0.001).Relationship between thought and perception disorders
and functioning areas
In the BPD group (Table 5), no significant bivariate corre-
lations were found between the three DIB-R subsections,
whereas in the SC group (Table 6) the non-delusional
paranoia subsection score was significantly correlated with
psychotic experiences subsection score (τ (54) = 0.45,
p = 0.001).
In the BPD group (Table 5) the PSP area A score (so-
cially useful activities) was significantly correlated with
the PSP area B score (personal and social relationships)
and the PSP area C score (self-care), whereas in the SC
group (Table 6) the PSP area A score was significantly
correlated with scores for all the other areas and the
PSP area C score was correlated with the PSP area D
(disturbing and aggressive behaviors) score (τ (54) = 0.61,
p < 0.001).
Neither the DIB-R cognitive section nor any of the
DIB-R cognitive subsections were significantly correlated
with PSP total score in either group. For the SC group
there were no correlations between DIB-R cognitive sub-
sections and PSP areas (Table 6); however the DIB-R
non-delusional paranoia subsection was significantly
correlated with PSP area B (τ (54) = 0.54, p = 0.002) and,
to a lesser extent with PSP area C (τ (54) = 0.34, p = 0.047).Predicting value of functioning areas for thought and
perception disorders
The linear regression analysis showed that for the SC
group the proportion of the variance explained by all the
models was very low (odd thinking/unusual perceptual
experiences: R2 = 0.09, F (4,23) = 0.68, p = 0.680; non-
delusional paranoia: R2 = 0.05, F (4,23) = 0.35, p = 0.840;
psychotic experiences: R2 = 0.20, F (4,23) = 1.44, p = 0.253).
Furthermore none of four PSP areas was a significant pre-
dictor of scores on any of the DIB-R subsections.
For the BPD group two models explained low propor-
tions of the variance in the dependent variable and did not
reach statistical significance (odd thinking/ unusual per-
ceptual experiences: R2 = 0.14, F (4,23) = 0.91, p = 0.473;
psychotic experiences: R2 = 0.10, F (4,23) = 0.65, p = 0.631)
and none of PSP areas showed significant predictive value.
However, as shown in Table 7, the model with non-
delusional paranoia as the dependent variable explained
36.1% of the variance (R2 = 0.36, F = 3.25, p = 0.030) and in
this model PSP area B score significantly predicted non-
delusional paranoia (β = −0.16, t (23) = 2.90, p = 0.008).
Table 4 PSP scores for the BPD group and SC group
SC (n = 28) DBP (n = 28)
PSP area Media(SD) Median(IQR) Media(SD) Median(IQR) p
Area A 3.32(0.77) 3(1) 3.35(0.73) 3.5(1) 0.860a
Area B 3.39(0.57) 3(1) 3.39(0.57) 3(1) 1a
Area C 2.18(0.67) 2(1) 2.21(0.74) 2(2) 0.850a
Area D 2.07(0.94) 2(1) 3(0.72) 3(2) <0.001a
PSP total score 52.68(9.28) 50(14) 48.93(10.75) 47.5(20) 0.168a
SC: schizophrenia; BPD: Borderline Personality Disorder; IQR: interquartile range; Area A: useful activities; Area B: personal and social relationships; Area C: self-care;
Area D: disturbing and aggressive behaviors.
aMann–Whitney U test.
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As expected, patients with BPD showed less severe symp-
toms than those with SC, as indicated by higher scores on
both DIB-R cognitive section and DIB-R psychotic experi-
ence subsection.
The overall cognitive pattern shown by BPD patients
in our investigation seems to be roughly consistent with
that reported by previous authors who used the same
tool to assess DSM-III BPD [17,20,21]: the BPD group
presented (a) ubiquitous odd thinking, unusual perceptual
experiences and non-delusional paranoia; (b) frequent
transient, circumscribed and atypical psychotic experi-
ences (i.e. quasi-psychotic thought), and (c) some ongoing,
bizarre, Schneiderian first-rank symptoms (i.e. true psych-
otic thought).
Zanarini and colleagues [21] suggested that quasi-
psychotic thought was “virtually pathognonomic” for
BPD because of its high prevalence in their BPD group
(40%) and its absence from their SC group (0%) whereas
in the present study this type of thought, although more
frequent in the BPD group (82.1%), was also encoun-
tered in around half the SC group and therefore does
not seem to discriminate between BPD and SC. The
high prevalence of quasi-psychotic thought in our SCTable 5 Correlations between DIB-R and PSP in the BPD grou
DIB-R C PODD PPAR PPSY
DIB-R C 1 - - -
PODD 0.839** 1 - -
PPAR 0.401** 0.179 1 -
PPSY 0.518** 0.216 0.180 1
PSP tot −0.198 −0.102 −0.301 −0.114
Area A 0.099 0.062 0.221 0.039
Area B 0.168 0.066 0.544** 0.052
Area C −0.061 −0.123 0.339* −0.003
Area D 0.231 0.212 0.067 0.048
DIB-R C: DIB-R cognitive section; PODD: odd thinking/unusual perceptual experienc
total score; Area A: useful activities; Area B: personal and social relationships; Area C
**Kendall’s tau-b, p < 0.01 (2-tailed).
*Kendall’s tau-b, p < 0.05 (2-tailed).group compared to that of Zanarini and colleagues [21]
might be explained by the difference in setting (outpatients
only vs. outpatients and community inpatients) or by dif-
ferences in psychopharmacological treatments (e.g. first-
vs. second- generation antipsychotics, oral vs. long- acting
injectable agents etc.), specifically antipsychotic agents
might have controlled and altered the clinical expression
of some psychotic episodes in our SC patients.
The prevalence of true psychotic thought in DSM-III
BPD reported in previous studies which used DIB-R
ranged from 0% [21] to 3.8% [46], whereas in the present
study almost half the DSM-IV BPD group (46.4%) re-
ported at least one true psychotic experience during the
previous two years. This finding seems to be consistent
with some recent studies of psychopathology in DSM-IV
BPD, which reported a noteworthy prevalence of persist-
ent psychotic symptoms, even if a careful comparison is
complicated by differences in samples and methods. For
instance, Kingdom and colleagues [27] reported that
29% of BPD patients had paranoid delusions according
to SCID-I and 50% had auditory hallucinations accord-
ing to PSYRATS, but this study did not exclude or take
into account substance use disorder; they failed to find
significant differences in the persistence of hallucinationsp
PSP tot Area A Area B Area C Area D
- - - - -
- - - - -
- - - - -
- - - - -
1 - - - -
−0.546** 1 - - -
−0.456** 0.430* 1 - -
−0.496** 0.438* 0.306 1 -
−0.497** 0.262 0.089 0.141 1
es; PPAR: non-delusional paranoia; PPSI: psychotic experiences; PSP tot: PSP
: self-care; Area D: disturbing and aggressive behaviors.
Table 6 Correlations between DIB-R and PSP in the SC group
DIB-R C PODD PPAR PPSY PSP tot Area A Area B Area C Area D
DIB-R C 1 - - - - - - - -
PODD 0.885** 1 - - - - - - -
PPAR 0.349* 0.274 1 - - - - - -
PPSY 0.695** 0.447** 0.158 1 - - - - -
PSP tot −0.076 −0.062 −0.016 −0.130 1 - - - -
Area A −0.099 −0.141 −0.056 0.047 −0.748** 1 - - -
Area B 0.196 0.092 0.122 0.242 −0.575** 0.390* 1 - -
Area C 0.017 0.028 −0.039 0.087 −0.508** 0.403* 0.247 1 -
Area D −0.078 0.045 −0.061 −0.111 −0.537** 0.433* 0.259 0.611** 1
DIB-R C: DIB-R cognitive section; PODD: odd thinking/unusual perceptual experiences; PPAR: non-delusional paranoia; PPSI: psychotic experiences; PSP tot: PSP
total score; Area A: useful activities; Area B: personal and social relationships; Area C: self-care; Area D: disturbing and aggressive behaviors.
**Kendall’s tau-b, p < 0.01 (2-tailed).
*Kendall’s tau-b, p < 0.05 (2-tailed).
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http://www.biomedcentral.com/1471-244X/14/239in BPD and SC. Yee and colleagues [29] reported that
29.2% of 171 patients with BPD assessed by SCL-90 heard
voices, but their qualitative assessment of perception
disorders was carried out son a non-random subsample
of ten cases. Pearse and colleagues [30] found highest
lifetime prevalence of psychotic symptoms in DSM-IV
BPD (80%), but 75% of the sample had a history of alcohol
and/or illicit drug use, and affective disorders were not
excluded.
The prevalence of quasi-psychotic thought in our sam-
ple of DSM-IV BPD was also higher than that found by
Zanarini and colleagues [21] in a DSM-III BPD sample
using the same assessment tool (82.1% vs. 40%).
Taken together, these findings suggest that changes in
the DSM definition of BPD (i.e. the introduction of the
ninth diagnostic criterion and the more complete de-
scription of BPD) may have increased its sensitivity to
psychotic and psychotic-like symptoms leading to the in-
clusion of patients who have had psychotic episodes that
were not severe enough to meet criteria for either brief
psychotic disorder or another Axis I psychotic disorder
(e.g. the criteria proposed by DSM-5 for Attenuated
Psychosis Syndrome). Given that in the present studyTable 7 Linear regression of PSP areas on non-delusional
paranoia in the BPD group (n = 28)a
R2 = 0.361, Adjusted R2 = 0.250, F(4,23) = 3.254, p = 0.030*
Independent variables β t p
Area A 0.076 −0.789 0.438
Area B −0.165 2.903 0.008*
Area C 0.549 1.249 0.224
Area D 0.238 0.435 0.667
Area A: useful activities; Area B: personal and social relationships; Area
C: self-care; Area D: disturbing and aggressive behaviors.
aadjusted for socio-demographic variables that differed significantly
between groups.
*p < 0.05 (2-tailed).the mean psychotic experiences score for the BPD group
was one third of the score for the SC group, we suggest
that a severity scale for psychotic symptoms, such as the
Clinician-Rated Dimensions of Psychosis Symptom Severity
introduced in DSM-5, might be used to improve the assess-
ment of psychotic symptoms in BPD as it would allow a
more careful distinction between the psychotic features of
BPD and SC. However, placing this dimensional scale in
DSM-5 Section III is unlikely to be the most effective way
to encourage its use, as Maj [47] has already noted.
Overall functioning was similar in the two groups;
however aggressive acts and socially disturbing behavior
were more frequent in the BPD group than the SC
group, even considering that antipsychotic therapy may
have had a crucial role in decreasing violent behavior in
SC patients [48].
Our most important finding about the relationship
between thought disorders and functioning concerns
non-delusional paranoia. Not only were symptoms of
non-delusional paranoia more severe and more frequent
in the BPD group than SC group, consistent with the re-
sults of Zanarini and colleagues [21], but their severity
was correlated with and predicted by the level of personal
and social functioning in the BPD group, but not the SC
group. These results are consistent with the most influen-
tial psychodynamic perspectives [7,9,10,12] in suggesting
that severe difficulties in interpersonal functioning induce
the development of undue suspiciousness, ideas of refer-
ences and other symptoms of non-delusional paranoia in
BPD patients.
Despite the differences in methods, our results appear
to be consistent with those of Suzuki and colleagues [37]
and Glaser and colleagues [38] and support the concept
of stress-related thought disorder. However in the present
study there was neither a correlation between non-
delusional paranoia and psychotic experiences nor any
functioning areas worked as predictor for psychotic
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http://www.biomedcentral.com/1471-244X/14/239experience, so low interpersonal functioning did not
appear to induce psychotic experiences in BPD pa-
tients and thus, unlike Glaser and colleagues [38], we
found no evidence in our BPD group of either true
psychotic reactivity or quasi-psychotic reactivity, only
stress-related non-delusional paranoia.
Our findings are therefore consistent with the reference
to “stress-related paranoid ideation” included in the ninth
diagnostic criterion for DSM-IV BPD and maintained in
DSM-5, and suggest that it is still a valid and essential dis-
criminating feature for BPD.
The lack of a prospective longitudinal assessment of
functioning and psychopathology is an important limita-
tion of the present study; this made it impossible to infer
a true causal relationship between the interpersonal
functioning and non-delusional paranoia; we can only
suggest that level of interpersonal functioning is associ-
ated with the severity of non-delusional paranoia over
the last two years, we could not determine whether the
development of non-delusional paranoia in BPD patients
was due to a worsening of personal or social functioning.
In view of the strong association between psychotic
disorders and substances use disorder [17,21], the ad-
ministration of a urine drug test alongside SCID-I would
have enhanced the accuracy of sample selection and thus
the characterization of thought and perception disorders
in the two diagnostic groups.
Furthermore, the limited sample size and the lack of
information about non-antipsychotic pharmacological
treatment assumed by patients should be considered as
two other limitations of the present study since they
both could affect the accuracy of results.
Future research on BPD might investigate the rela-
tionship between personal and social functioning, non-
delusional paranoia, and thought and perception disor-
ders prospectively in order to determine whether non-
delusional paranoia is due to changes in interpersonal
functioning and whether and how it may evolve into
quasi- or true psychotic experience.
Conclusion
BPD patients reported less severe psychotic experiences
with less frequent true psychotic thought, more frequent
quasi-psychotic thought, and more severe non-delusional
paranoia than SC patients. Interpersonal functioning
seems to predict non-delusional paranoia in BPD, which
would validate the “stress-related paranoid ideation”, in-
cluded in the ninth diagnostic criterion for DSM-IV and
DSM-5 BPD. PBD patients had higher scores on the
psychotic experiences subscale that support the use of a
dimensional assessment of the severity of thought and
perception disorders, for example the Clinician-Rated Di-
mensions of Psychosis Symptom Severity introduced in
DSM-5, Section III.These results are consistent with the most influential
psychodynamic perspectives in suggesting that severe
difficulties in interpersonal functioning induce the develop-
ment of undue suspiciousness, ideas of references and other
symptoms of non-delusional paranoia in BPD patients.
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